🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
7.93
+1.18 (17.48%)
At close: Nov 19, 2026, 4:00 PM EST
8.48
+0.55 (6.94%)
After-hours: Nov 19, 2026, 7:46 PM EST

Moleculin Biotech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7.298.884.2823.5543.1570.9
Cash & Short-Term Investments
7.298.884.2823.5543.1570.9
Cash Growth
8.71%107.53%-81.83%-45.42%-39.15%367.30%
Other Receivables
-0.010.020.10.020.05
Receivables
-0.010.020.10.020.05
Prepaid Expenses
1.120.520.572.081.631.06
Other Current Assets
-0.280.330.550.80.49
Total Current Assets
8.419.695.1926.2745.672.5
Property, Plant & Equipment
0.280.390.580.80.680.45
Other Intangible Assets
11.1511.1511.1511.1511.1511.15
Other Long-Term Assets
0.90.9----
Total Assets
20.7422.1316.9338.2257.4284.09

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.73.512.032.52.11.36
Accrued Expenses
2.443.213.214.222.612.16
Current Portion of Leases
-0.140.120.10.120.1
Total Current Liabilities
6.146.855.366.824.823.62
Long-Term Leases
0.110.220.360.470.340.06
Other Long-Term Liabilities
0.010.04-4.860.081.41
Total Liabilities
6.257.125.7212.145.235.1

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
00-0.030.030.03
Additional Paid-In Capital
247.56221183.69157.65153.99151.73
Retained Earnings
-232.98-206-172.44-131.6-101.84-72.81
Comprehensive Income & Other
-0.090.01-0.04-0.010.010.04
Shareholders' Equity
14.4915.0111.2126.0752.1978.99
Total Liabilities & Equity
20.7422.1316.9338.2257.4284.09

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.110.360.480.570.450.16
Net Cash (Debt)
7.188.523.822.9842.6970.74
Net Cash Growth
13.73%124.18%-83.46%-46.18%-39.65%374.92%
Net Cash Per Share
21.01143.83----
Filing Date Shares Outstanding
1.060.270.03---
Total Common Shares Outstanding
1.050.16----
Working Capital
2.282.83-0.1719.4640.7868.88
Book Value Per Share
13.8693.81----
Tangible Book Value
3.343.860.0614.9341.0467.85
Tangible Book Value Per Share
3.2024.12----
Machinery
-1.181.161.171.040.98
SEC Filings: 10-K · 10-Q